Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Aug 30, 2024

SELL
$1.81 - $2.7 $4,163 - $6,210
-2,300 Closed
0 $0
Q2 2021

Aug 30, 2024

BUY
$2.07 - $2.89 $4,761 - $6,647
2,300 New
2,300 $6.28 Million
Q4 2020

Aug 30, 2024

BUY
$1.91 - $5.63 $4,393 - $12,949
2,300 New
2,300 $6.39 Million

Others Institutions Holding SIOX

About Sio Gene Therapies Inc.


  • Ticker SIOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,975,200
  • Description
  • Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...
More about SIOX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.